News
AACR Annual Meeting 2018: Nanobiotix Presented Preclinical Data Showing NBTXR3 Nanoparticles Can Activate the cGAS-STING Pathway
PARIS& CAMBRIDGE, Mass.---- Regulatory News:. NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the local treatment of cancer, today announced that preclinical data evaluating the activation of the cGAS-STING pathway by NBTXR3 has been presented at the American Association for Cancer Research Annual Meeting 2018 in Chicago,...
PARIS& CAMBRIDGE, Mass.---- Regulatory News:. NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the local treatment of cancer, today announced that preclinical data evaluating the activation of the cGAS-STING pathway by NBTXR3 has been presented at the American Association for Cancer Research Annual Meeting 2018 in Chicago,...